Market Watch – Page 549 – Biotech Insider

All Posts in "Market Watch"

Gold posts a loss for the session and week as Powell eases worries about the economy

Powell says the Fed is ‘not forecasting or expecting a recession’

by Editor — September 07, 2019 By Editor in Market Watch

Dow, S&P 500 book 3rd day of gains, as stock market caps off solid week despite tepid jobs report

Fed’s Jerome Powell says jobs report reflects healthy labor market, speaking at a panel in Zurich

by Editor — September 07, 2019 By Editor in Market Watch

Three technology stocks to watch include Twitter

Also: Lattice Semiconductor and Sonos

by Editor — September 07, 2019 By Editor in Market Watch

Apple iPhone launch event: 5 things to watch for

Smartphone giant expected to roll out new iPhones and some long-awaited details about its streaming services on Sept. 10

by Editor — September 07, 2019 By Editor in Market Watch

Intel is optimistic about cloud spending and an AMD price battle

Chip-related stocks had a second straight day of 3% gains on Thursday

by Editor — September 06, 2019 By Editor in Market Watch

Telenav tries to reassure investors after stock plummets 45% on GM-Google deal

Company says no impact expected for fiscal 2020, 2021

by Editor — September 06, 2019 By Editor in Market Watch

Why silver may have more room to run

Critical information for the U.S. trading day

by Editor — September 06, 2019 By Editor in Market Watch

Dow notches best day in 3 weeks on rising trade optimism, rosier economic data

Call between Vice Premier Liu He and U.S. Trade Representative Robert Lighthizer tentatively set the stage for a resumption of talks

by Editor — September 06, 2019 By Editor in Market Watch

Slack shares plunge 15% on weak earnings guidance

Q2 results beat analysts’ estimates, but Q3 forecast revives growth concerns

by Editor — September 05, 2019 By Editor in Market Watch

Here are five things to know about Apple’s $7 billion bond deal

Investors pile some $25 billion of orders into the debt offering

by Editor — September 05, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.